Urolesan capsules No. 40 (10x4)

Storage active substances: 1 capsule contains Urolesan® thick extract obtained from a mixture of liquid extracts from Daucus carota L., fructus (carrot wild fruit) (1:1), Humulus lupulus L., flos (hop cones) (1:1), Oreganum vulgare L., herba (motherwort) (1:1) in a ratio of 1/1.4/1, extractant – ethanol 96% v/v, calculated on 10% moisture – 10.70 mg, Mentha x piperita L., aetheroleum (peppermint oil) – 7.46 mg, Abies sibirica L., aetheroleum (Siberian fir oil) – 25.50 mg. excipients: magnesium aluminum metasilicate; castor oil; heavy magnesium carbonate; talc; lactose, monohydrate; disodium edetate (Trilon B); potato starch. Medicinal form Capsules. The main physical and chemical properties: hard gelatin capsules with the number "0", body and lid are green. The contents of the capsule are a granular powder and/or compacted mass from yellow-gray to gray-brown in color with a greenish tint with impregnations and the smell of peppermint and fir oils. The presence of agglomerates that crumble when pressed is allowed. Pharmacotherapeutic group Means used in urology. ATX code G04B X. Pharmacological properties Combined preparation of plant origin. The components of Urolesan® reduce inflammatory phenomena in the urinary tract and kidneys, promote increased blood circulation in the kidneys and liver, have a diuretic, antibacterial, choleretic effect, form a protective colloid in the urine, and normalize the tone of the smooth muscles of the upper urinary tract and gall bladder. Urolesan® increases the release of urea and chlorides, promotes the removal of small stones and sand from the bladder and kidneys. Indication Acute and chronic infections of the urinary tract and kidneys (cystitis and pyelonephritis); urolithiasis and uric acid diathesis (prevention of calculi formation after their removal); chronic cholecystitis (including calculous), biliary tract dyskinesia, gallstone disease. Contraindication Increased sensitivity to the components of the drug; gastritis (with the exception of gastritis with secretory insufficiency), peptic ulcer disease of the stomach and duodenum. Interaction with other medicinal products and other forms of interaction Not studied. Features of use Do not use the drug if the diameter of the concretions exceeds 3 mm. The drug contains excipients lactose and potato starch, so patients with rare hereditary forms of galactose intolerance, lactase deficiency, glucose-galactose malabsorption syndrome, or with increased sensitivity or intolerance to gluten cannot use the drug in this dosage form. Use during pregnancy or breastfeeding The use of the drug during pregnancy or breastfeeding has not been studied. The ability to influence the speed of reaction when driving a motor vehicle or working with other mechanisms Not studied. Method of application and dosage Take the drug orally before meals. Recommended dosage for adults and children over 14 years of age: 1 capsule 3 times a day. In acute conditions (including renal and hepatic colic), the duration of the therapy course is from 5 to 7 days, in chronic conditions - from 7 days to 1 month. In the event of renal and hepatic colic, the single dose can be increased once to 2 capsules, after which the next dose can be returned to the usual single dose (1 capsule). Children Children under 14 should be prescribed Urolesan® in the form of syrup or liquid. Overdose In case of an overdose, nausea, dizziness, and an increase in the sedative effect of the drug are possible. Treatment: The therapy is symptomatic. Intensive warm drinking, calmness, activated charcoal, atropine sulfate (0.0005-0.001 g). Side effects Urolesan® is usually well tolerated. When using the drug, the following are possible: from the digestive tract: dyspeptic disorders (including nausea, vomiting); allergic reactions, including hyperemia, urticaria, a feeling of itching, redness of the face, skin rashes, angioedema (including a feeling of itching in the throat, difficulty breathing, swelling of the face, tongue); from the central and peripheral nervous system: dizziness, general weakness; from the side of the cardiovascular system: arterial hypertension, hypotension, pain in the region of the heart. Expiration date 3 years. Storage conditions Store in the original packaging at a temperature not higher than 25°C. Keep out of the reach of children. Packaging 10 capsules in a blister, 4 blisters in a pack. Leave category Without a prescription. Producer PJSC "Kyivmedpreparat".